Long Term Model for Evaluation of Myocardial Metabolic Recovery following Global Ischemia

  • John St. Cyr
  • Herbert Ward
  • Jolene Kriett
  • David Alyono
  • Stanley Einzig
  • Richard Bianco
  • Robert Anderson
  • John Foker
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 194)


Myocardial ATP levels remain depressed following significant periods of ischemia (Isc) despite reperfusion (Rpf). Neither the rate of in vivo ATP return following global Isc nor the factors which influence recovery have been defined. In order to determine the time course to complete the return of ATP levels and evaluate methods of enhancing recovery of ATP levels, we have devised a chronic canine model of global Isc. In this model serial ventricular biopsies can be taken in the awake animal over several days without reoperation which allows an investigation of the recovery of the myocardium following a uniform global insult to be performed.

Recovery of ATP levels has been shown to depend, at least in part, on the availability of precursors and the activity of the ATP regenerating enzymes. Because complete recovery of ATP levels takes days, short term (hours) models have limitations. Previous attempts at enhancing ATP recovery,following Isc have been only partially successful because either the degree of depression was not great or the period of observation was short, resulting in incomplete return. To identify the best precursor choice, we previously measured the activity of the AMP regenerating enzymes, adenosine kinase (AdK) (adenosine → AMP) and adenine phosphoribosyl transferase (APRT) (adenine → AMP). Because APRT activity was 20 fold higher than AdK with similar Km values for substrates, it appeared that adenine (A) is preferred to adenosine for AMP regeneration in the dog’s myocardium. The formation of 5-phosphoribosyl 1-pyrophosphate (PRPP) may also be rate limiting and, therefore, the effect of ribose (R) on ATP recovery was also evaluated. Recovery of ATP levels was assessed in three groups: (1) normal saline (NS), (2) A (20 mM) in normal saline (A/NS) or (3) A with R (80 mM) in normal saline (A/R) were infused (1.0 ml/min) into the right atrium of dogs for 48 hours following Isc. In all groups, ATP levels fell to between 46–60% of pre-Isc levels during Isc. In the NS dogs, ATP levels continued to fall slightly to 46% pre-Isc levels during the first four hours of Rpf after Isc. By 24 hours no appreciable recovery had occurred and the measured ATP was only 51% of the pre-Isc value. Even by seven days, ATP had not returned fully, and by extrapolation, complete recovery required 9.9±1.4 days. Treated dogs showed, however, that ATP recovery could be significantly enhanced. In the A/NS treated group, the ATP levels rebounded to 69% of pre-Isc values during the first four hours of Rpf following Isc but recovery leveled off during the next 20 hours. Recovery in the A/R treated group rose to 60% of pre-Isc values after four hours of Rpf and continued to improve thereafter. Recovery was virtually complete by 24 hours (96%). The calculated mean recovery rate for the first 24 hours in each group: (NS) 0.04±0.33 nmoles/mg wet wt/day, (A/NS) 0.41±0.55 nmoles/mg wet wt/day and (A/R) 2.44±0.38 nmoles/mg wet wt/day. Our results reveal that (1) This long term model allows serial myocardial sampling in the awake state for investigation of recovery from Isc. (2) ATP recovery following a significant global Isc insult is slow. (3) Precursor availability is an important limiting factor in recovery. (4) Recovery time can be greatly shortened with ATP precursor infusion even when started after Isc. (5) Although A alone initially enhanced ATP recovery, the addition of R provided a more rapid complete return suggesting PRPP formation is also rate limiting.


Coronary Sinus Adenine Nucleotide Coronary Vascular Resistance Canine Myocardium Adenine Phosphoribosyl Transferase 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    E.S. Benson, G.T. Evans, B.E. Hallaway, C. Phibbs, E.F. Freier, Myocardial creatine phosphate and nucleotides in anoxic cardiac arrest and recovery, Amer J Physiol 201: 687–93 (1961).Google Scholar
  2. 2.
    R.M. Berne, The role of adenosine in the regulation of coronary blood flow, Circ Res 47: 807–13 (1980).PubMedGoogle Scholar
  3. 3.
    J.E. Foker, S. Einzig, T. Wang, Adenosine metabolism and myocardial preservation, J Thorac Cardiovasc Surg 80: 506–16 (1980).PubMedGoogle Scholar
  4. 4.
    W. Isselhard, D.H. Hinzen, E. Geppert, W. Maurer, Effect of substrate supply on post-asphyctic restoration of adenine nucleotides in rabbit hearts in vivo, Pflugers Arch 320: 195–209 (1970).PubMedCrossRefGoogle Scholar
  5. 5.
    D.F. DeWitt, K.E. Jochim, D.M. Behrendt, Nucleoside degradation and function impairment during cardioplegia: Amelioration by inosine, Circ 67: I: 171–78 (1983).Google Scholar
  6. 6.
    O.A. Smiseth, Inosine infusion in dogs with acute ischoemic left ventricular failure: favourable effects on myocardial performance and metabolism, Cardiovasc Res 17: 19–209 (1983).CrossRefGoogle Scholar
  7. 7.
    H.B. Ward, T. Wang, S. Einzig, R.W. Bianco, J.E. Faker, Enhanced regeneration of postischemia myocardial adenosine triphosphate concentrations, Surg Forum XXXII: 254–6 (1981).Google Scholar
  8. 8.
    C. Nienaber, M. Mauser, W. Schaper, Stimulation of myocardial adenine nucleotide synthesis by postischemic reperfusion with direct purine precursor AICAR* comparison with ribose. (*5-amino-4-imidzole-carboxamide-riboside). J Amer Coll Cardiol, 1 (2): 667 (1983).Google Scholar
  9. 9.
    R.L. Sabina, K.H. Kernstine, R.L. Boyd, E.W. Holmes, J.L. Swain, Metabolism of 5-amino-4-imidazolecarboxamide riboside in cardiac and skeletal muscle: Effects on purine nucleotide synthesis, J Biol Chem 257: 10178–83 (1982).PubMedGoogle Scholar
  10. 10.
    M.K. Pasque, T.L. Spray, G.L. Pellom, P. Van Trigt, R.B. Peyton, W.D. Currie, A.S. Wechsler, Ribose-enhanced myocardial recovery following ischemia in the isolated working rat heart, J Thorac Cardiovasc Surg 83: 390–8 (1982).PubMedGoogle Scholar
  11. 11.
    H.B. Ward, T. Wang, S. Einzig, R.W. Bianco, J.E. Foker, Prevention of ATP catabolism during myocardial ischemia: A preliminary report. J Surg Res 34: 292–7 (1983).PubMedCrossRefGoogle Scholar
  12. 12.
    H.G. Zimmer, Normalization of depressed heart function in rats by ribose, Science 220: 81–2 (1983).PubMedCrossRefGoogle Scholar
  13. 13.
    H.B. Ward, S. Einzig, T. Wang, R.W. Bianco, J.E. Foker, Comparison of catecholamine effects on myocardial metabolism and regional blood flow during and after cardiopulmonary bypass, J Thorac Cardiovasc Surg 87: 3: 452–465 (1984).PubMedGoogle Scholar
  14. 14.
    W. Lamprecht, P. Stein, F. Heinz, H. Weisser, in: Methods of enzymatic analysis, H.U. Bergmeyer, ed., Academic Press, Inc., New York (1974).Google Scholar
  15. 15.
    D. Jaworek, W. Gruber, H.U. Bergmeyer, Adenosine-5’-diphosphate and adenosine-5’-monophosphate, in: Methods of enzymatic analysis, H.U. Bergmeyer, ed., Academic Press, Inc., New York (1974).Google Scholar
  16. 16.
    H.K. Webster, J.M. Whaun, Application of simultaneous UV-radioactivity high-performance liquid chromatography to the study of intermediary metabolism. I. Purine nucleotides, nucleosides and bases, J Chromatograph 209: 283–92 (1981).CrossRefGoogle Scholar
  17. 17.
    M.A. Heymann, B.D. Payne, J.I. Hoffman, A.M.Rudolph, Blood flow measurements with radionuclide-labeled particles, Progress in Cardiovasc Diseases 20: 55 (1977).CrossRefGoogle Scholar
  18. 18.
    P.M. Consigny, Acute and chronic microsphere loss from canine left ventricular myocardium, Amer J Physiol 242: H393–404 (1982).Google Scholar
  19. 19.
    S. Wallenstein, C.L. Zucker, J.L. Fleiss, Some statistical methods useful in circulation research. Circ Res 47: 1–9 (1980).PubMedGoogle Scholar
  20. 20.
    R.A. Kloner, L.W.V. DeBoer, J.R. Darsee, J.S. Ingwall, E. Braunwald, Recovery from prolonged abnormalities of canine myocardium salvaged from ischemic necrosis by coronary reperfusion. Proc Natl Acad Sci USA 78: 7151–6 (1981).CrossRefGoogle Scholar
  21. 21.
    H.G. Zimmer, H. Ibel, U. Suchner, H. Schad, Ribose Intervention in the cardiac pentose phosphate pathway is not species-specific, Science 223: 712–714 (1984).PubMedCrossRefGoogle Scholar
  22. 22.
    H.B. Ward, J.M. Kriett, S. Einzig, R.W. Bianco, R.W. Anderson, J.E. Foker, Adenine nucleotides and cardiac function following global myocardial ischemia, Surg Forum XXXIV: 264–6 (1983).Google Scholar
  23. 23.
    J.M. Kriett, H.B. Ward, R.W. Bianco, S. Einzig, D. Alyono, R.W. Anderson, J.E. Foker, Recovery of adenine nucleotides and cardiac function following ischemia, Circ 68 (II1): 389 (1983).Google Scholar

Copyright information

© Plenum Press, New York 1986

Authors and Affiliations

  • John St. Cyr
    • 1
  • Herbert Ward
    • 1
  • Jolene Kriett
    • 1
  • David Alyono
    • 1
  • Stanley Einzig
    • 1
  • Richard Bianco
    • 1
  • Robert Anderson
    • 1
  • John Foker
    • 1
  1. 1.Department of SurgeryUniversity of MinnesotaMinneapolisUSA

Personalised recommendations